Genotyping HLA alleles to predict the development of Severe cutaneous adverse drug reactions (SCARs): state-of-the-art

T Jantararoungtong, T Tempark… - Expert Opinion on …, 2021 - Taylor & Francis
Introduction: Pharmacogenomics has great potential in reducing drug-induced severe
cutaneous adverse drug reactions (SCARs). Pharmacogenomic studies have revealed an …
被引用次数：21 相关文章

Genotyping HLA alleles to predict the development of Severe cutaneous adverse drug reactions (SCARs): state-of-the-art

T Jantararoungtong, T Tempark… - Expert Opinion on …, 2021 - mahidol.elsevierpure.com
Introduction: Pharmacogenomics has great potential in reducing drug-induced severe
cutaneous adverse drug reactions (SCARs). Pharmacogenomic studies have revealed an …

Genotyping HLA alleles to predict the development of Severe cutaneous adverse drug reactions (SCARs): state-of-the-art

T Jantararoungtong, T Tempark… - Expert opinion on …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction: Pharmacogenomics has great potential in reducing drug-induced severe
cutaneous adverse drug reactions (SCARs). Pharmacogenomic studies have revealed an …

Genotyping HLA alleles to predict the development of Severe cutaneous adverse drug reactions (SCARs): state-of-the-art.

T Jantararoungtong, T Tempark… - Expert Opinion on …, 2021 - europepmc.org
Introduction: Pharmacogenomics has great potential in reducing drug-induced severe
cutaneous adverse drug reactions (SCARs). Pharmacogenomic studies have revealed an …
[PDF] academia.edu

[PDF][PDF] Genotyping HLA alleles to predict the development of Severe cutaneous adverse drug reactions (SCARs): state-of-the-art

T Jantararoungtong, T Tempark… - EXPERT OPINION ON …, 2021 - academia.edu
Introduction: Pharmacogenomics has great potential in reducing drug-induced severe
cutaneous adverse drug reactions (SCARs). Pharmacogenomic studies have revealed an …